You are here

BCT303

IPE Kicks Off Phase-2 Clinical Trial for New Hypothyroid Drug

CP Wire

Wed, 06/12/13 - 12:28 pm

clinical trials

IPE receives FDA approval for Phase 2 clinical trials for BCT303 for hypothyroidism

CP Wire

Wed, 01/30/13 - 01:30 pm

IPE receives FDA approval for Phase 2 clinical trials for BCT303 for hypothyroidism

Wed, 01/30/13 - 01:27 pm